Purple Biotech (PPBT) Selling, General & Administrative (2014 - 2026)
Powered by 
Analysis
Purple Biotech (PPBT) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.95 Bn | 195.96 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 180.35 Bn | 177.17 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.62 Bn | 74.62 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.19 Bn | 56.00 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.75 Bn | 30.44 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.58 Bn | 30.30 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.42 Bn | 29.42 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Purple Biotech | 299,221.53 | 299,221.53 | - | 597,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 597,000.00 |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 780,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 646,000.00 |
| Dec 31, 2024 | 558,000.00 |
| Sep 30, 2024 | 785,000.00 |
| Jun 30, 2024 | 865,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.91 Mn |
| Sep 30, 2021 | 1.42 Mn |